Compound atlas
Cognitive

P21

Also known as · P-21 · Cerebrolysin fragment analog

Peptide
Half-life
6h
approx. mean t½
Dose range
0.5–1 mg
typical, not prescriptive
Category
Cognitive
primary use-case
Single-dose decay
t½ = 6h · first-order model
~24h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m6h12h18h24h30h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A neurogenic peptide studied for promoting hippocampal neurogenesis and cognitive support.

Mechanism of action

Mimics aspects of neurotrophic signaling, increasing BDNF and adult neurogenesis in preclinical models.

Typical protocol

0.5–1 mg subQ daily in short cycles.

Storage

Reconstituted: refrigerated, ~30 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.